Atorvastatin calcium
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
60290-041 -
Package NDC
60290-041-01 -
Package NDC
60290-041-02 -
Package NDC
60290-041-03 -
Package NDC
60290-041-04 -
Application number
ANDA213853 -
SPL ID
5e7cfae3-d0cb-9792-e063-6294a90aa6fa -
SPL set ID
5a7594ca-30be-4350-827f-ef745a2a7e18 -
UNII
A0JWA85V8F -
RxCUI
259255 -
RxCUI
617310 -
RxCUI
617311 -
RxCUI
617312
What the source publishes
- Labeler
- Umedica Laboratories USA Inc.
- Active ingredients
- Atorvastatin calcium
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Atorvastatin calcium",
"splId": "5e7cfae3-d0cb-9792-e063-6294a90aa6fa",
"labels": [
{
"setId": "5a7594ca-30be-4350-827f-ef745a2a7e18",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a7594ca-30be-4350-827f-ef745a2a7e18",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5a7594ca-30be-4350-827f-ef745a2a7e18"
}
],
"routes": [
"ORAL"
],
"labeler": "Umedica Laboratories USA Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (60290-041-01)",
"package_ndc": "60290-041-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20260215"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (60290-041-02)",
"package_ndc": "60290-041-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20260215"
},
{
"sample": false,
"description": "2500 TABLET in 1 BOTTLE (60290-041-03)",
"package_ndc": "60290-041-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20260215"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (60290-041-04)",
"package_ndc": "60290-041-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20260215"
}
],
"productId": "60290-041_5e7cfae3-d0cb-9792-e063-6294a90aa6fa",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "60290-041",
"deaSchedule": null,
"genericName": "Atorvastatin calcium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ATORVASTATIN",
"strength": "40 mg/1"
}
],
"applicationNumber": "ANDA213853",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260215",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175589",
"N0000000121"
],
"upc": [
"0360290039020",
"0360290041016",
"0360290039013",
"0360290040026",
"0360290040019",
"0360290042013"
],
"unii": [
"A0JWA85V8F"
],
"rxcui": [
"259255",
"617310",
"617311",
"617312"
],
"spl_set_id": [
"5a7594ca-30be-4350-827f-ef745a2a7e18"
],
"pharm_class_epc": [
"HMG-CoA Reductase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"
],
"manufacturer_name": [
"Umedica Laboratories USA Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:60290-041_5e7cfae3-d0cb-9792-e063-6294a90aa6fa"